Literature DB >> 2293701

Rationale for elective neck dissection in 1990.

M Friedman1, M F Mafee, B L Pacella, T L Strorigl, L L Dew, D M Toriumi.   

Abstract

Elective neck dissection has long been a subject of debate among surgeons. The proponents of elective neck dissection base their rationale on studies that show a 30% incidence of occult disease in those situations for which elective neck dissection is recommended. One hundred eighty-two patients with advanced stages of squamous cell carcinoma of the head and neck were studied. All patients had preoperative computed tomography or magnetic resonance imaging, and all patients had some form of radical neck dissection. The sensitivity of clinical exam was compared with the sensitivity of computed tomography or magnetic resonance imaging in ability to detect nodal disease. The sensitivity of clinical exam alone was 71.7%, while the sensitivity of computed tomography or magnetic resonance imaging was 91.1%. Based on physical exam alone, there would be a 39% rate of occult disease; if computed tomography or magnetic resonance imaging data is combined with physical exam, the occult disease rate would drop to 12%. All centers performing elective neck dissection must reassess their rationale or restudy their occult disease rate with computed tomography or magnetic resonance imaging.

Entities:  

Mesh:

Year:  1990        PMID: 2293701     DOI: 10.1288/00005537-199001000-00012

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  14 in total

1.  Value of the supraomohyoid neck dissection with frozen section analysis as a staging procedure in the clinically negative neck in squamous cell carcinoma of the oral cavity.

Authors:  F J van den Hoogen; J J Manni
Journal:  Eur Arch Otorhinolaryngol       Date:  1992       Impact factor: 2.503

Review 2.  Management of cervical lymph nodes in patients with head and neck cancer.

Authors:  G B Snow; P Patel; C R Leemans; R Tiwari
Journal:  Eur Arch Otorhinolaryngol       Date:  1992       Impact factor: 2.503

3.  Comparison of the efficacy of clinical examination, ultrasound neck and computed tomography in detection and staging of cervical lymph node metastasis in head and neck cancers.

Authors:  Nitin Anand; Neena Chaudhary; M K Mittal; Rajni Prasad
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2007-04-26

4.  Modern imaging techniques and ultrasound-guided aspiration cytology for the assessment of neck node metastases: a prospective comparative study.

Authors:  M W van den Brekel; J A Castelijns; H V Stel; R P Golding; C J Meyer; G B Snow
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

5.  Pathological findings in clinically false-negative and false-positive neck dissections for oral carcinoma.

Authors:  J A Woolgar; E D Vaughan; J Scott; J S Brown
Journal:  Ann R Coll Surg Engl       Date:  1994-07       Impact factor: 1.891

Review 6.  Oral cavity squamous cell carcinoma and the clinically n0 neck: the past, present, and future of sentinel lymph node biopsy.

Authors:  Andrew Coughlin; Vicente A Resto
Journal:  Curr Oncol Rep       Date:  2010-03       Impact factor: 5.075

7.  Considerations in the treatment of the node-negative (N0) neck in glottic carcinomas.

Authors:  János Elô; Zsuzsa Balatoni; Zsuzsa Kótai; Réka Bártfai
Journal:  Pathol Oncol Res       Date:  2003-02-11       Impact factor: 3.201

8.  Sentinel lymph node radiolocalization with 99mTc filtered tin colloid in clinically node-negative squamous cell carcinomas of the oral cavity.

Authors:  Han-Sin Jeong; Chung-Hwan Baek; Young-Ik Son; Do-Yeon Cho; Man Ki Chung; Jin-Young Min; Young-Hyeh Ko; Byung-Tae Kim
Journal:  J Korean Med Sci       Date:  2006-10       Impact factor: 2.153

9.  Radiotherapy in N0 head and neck cancer patients.

Authors:  J P Bataini
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

10.  A mathematical model using computed tomography for the diagnosis of metastatic central compartment lymph nodes in papillary thyroid carcinoma.

Authors:  Tianrun Liu; Xuan Su; Weichao Chen; Lie Zheng; Li Li; AnKui Yang
Journal:  Eur Radiol       Date:  2014-08-09       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.